A Monte Carlo evaluation of beam characteristics for total body irradiation at extended treatment distances
The aim is to study beam characteristics at large distances when focusing on the electron component. In particular, to investigate the utility of spoilers with various thicknesses as an electron source, as well as the effect of different spoiler‐to‐surface distances (STSD) on the beam characteristics and, consequently, on the dose in the superficial region. A MC model of a 15 MV Varian accelerator, validated earlier by experimental data at isocenter and extended distances used in large‐field total body irradiation, is applied to evaluate beam characteristics at distances larger than 400 cm. Calculations are carried out using BEAMnrc/DOSXYZnrc code packages and phase space data are analyzed by the beam data processor BEAMdp. The electron component of the beam is analyzed at isocenter and extended distances, with and without spoilers as beam modifiers, assuming vacuum or air surrounding the accelerator head. Spoiler thickness of 1.6 cm is found to be optimal compared to thicknesses of 0.8 cm and 2.4 cm. The STSD variations should be taken into account when treating patients, in particular when the treatment protocols are based on a fixed distance to the patient central sagittal plane, and also, in order to maintain high dose in the superficial region. PACS numbers: 87.55.D‐, 87.55.de, 87.55.K‐
Accurate dosimetric measurement of large extended SSD fields for comparison to TPS models.
PURPOSE
There is little evidence in the literature which quantifies the accuracy of Treatment Planning Systems (TPSs) using large fields at extended SSD (eSSD). This paper introduces the approach taken at Christchurch Hospital, New Zealand to validate the use of the Monaco TPS for Total Body Irradiation (TBI) treatments.


METHODS
A purpose-built device for allowing precise movements of block-like phantoms called a Phantom Mobility Device (PMD) was used for collecting measurements at eSSD. These measurements were used for determining the ability of the Monaco TPS (originally validated for SSDs between 80 and 110 cm) to accurately model dose distributions for TBI treatments at Christchurch Hospital on either treatment machine one (T1) or two (T2) with SSD values of 341 and 432.6 and clinically useful field sizes of 120 and 170 cm, respectively.


RESULTS
We found that within the limits of measurement uncertainty the PMD contributed no determinable scatter to the measurements and proved a reliable approach for eSSD dose measurements. Additionally, by applying depth and off-axis distance constraints of use for TPS information it is possible to use the existing Monaco CCC model at eSSD for block phantom geometries. Dose Difference (DD) analysis showed a clinically acceptable agreement between the CCC model and measured data over a range of depths and off-axis distances.


CONCLUSIONS
The PMD was determined to be a useful tool for accurate measurement of extended SSD treatment fields. Monaco TPS CCC model agreed well for block phantoms so future comparisons to anthropomorphic phantoms or patient data are feasible.
Dose to superficial node for patients with head and neck cancer treated with 6 MV and 60Co photons.
The superficial neck nodes in only 1 out of 7 patients with head and neck cancer studied received more than 90% of the prescribed dose when treated with opposed 6 MV photons. Beam spoilers placed upstream from the patient enhanced the dose to the superficial node at the expense of higher dose to the skin.